HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $135 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor has reiterated a Buy rating on Incyte (NASDAQ: INCY) and maintained a price target of $135 for the stock.